This list is based on the watchlists of people on Stock Events who follow ARTL. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Show more...
FAQ
What is Artelo Biosciences stock price today?▼
The current price of ARTL is $6.90 USD — it has increased by +10.93% in the past 24 hours. Watch Artelo Biosciences stock price performance more closely on the chart.
What is Artelo Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Artelo Biosciences stocks are traded under the ticker ARTL.
Is Artelo Biosciences stock price growing?▼
ARTL stock has risen by +4.24% compared to the previous week, the month change is a -9.66% fall, over the last year Artelo Biosciences has showed a -94.7% decrease.
What is Artelo Biosciences market cap?▼
Today Artelo Biosciences has the market capitalization of 3.41M
When is the next Artelo Biosciences earnings date?▼
Artelo Biosciences is going to release the next earnings report on November 17, 2026.
What were Artelo Biosciences earnings last quarter?▼
ARTL earnings for the last quarter are -8.01 USD per share, whereas the estimation was -6.48 USD resulting in a -23.61% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Artelo Biosciences revenue for the last year?▼
Artelo Biosciences revenue for the last year amounts to 0 USD.
What is Artelo Biosciences net income for the last year?▼
ARTL net income for the last year is -12.88M USD.
How many employees does Artelo Biosciences have?▼
As of September 04, 2026, the company has 7 employees.
In which sector is Artelo Biosciences located?▼
Artelo Biosciences operates in the Health & Wellness sector.
When did Artelo Biosciences complete a stock split?▼
The last stock split for Artelo Biosciences was on August 31, 2026 with a ratio of 1:9.
Where is Artelo Biosciences headquartered?▼
Artelo Biosciences is headquartered in SOLANA BEACH, United States.